e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Are we effectively monitoring and treating vitamin D deficient patients with tuberculosis?
J. Murray, L. Wood, A. Jayaratnam (London, United Kingdom)
Source:
Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Session:
Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Session type:
Oral Presentation
Number:
4620
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Murray, L. Wood, A. Jayaratnam (London, United Kingdom). Are we effectively monitoring and treating vitamin D deficient patients with tuberculosis?. Eur Respir J 2013; 42: Suppl. 57, 4620
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Cholecalciferol supplementation in patients taking anti tuberculosis treatment
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Correlation between vitamin D receptor polymorphism with clinical and nutritional status in intensive phase treatment of pulmonary tuberculosis
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Vitamin D levels in patients with a clinical diagnosis of tuberculosis
Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Year: 2013
Vitamin D levels in patients with active TB: Is it clinically relevant?
Source: International Congress 2018 – Challenges in tuberculosis care
Year: 2018
Vitamin C levels in Indian patients with active pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010
Is it necessary to give tuberculosis treatment daily throughout?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Evaluation of vitamin D replacement in the tuberculosis patients
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012
Evaluation of the effect of Category I anti tuberculous therapy on the vitamin D status of pulmonary tuberculosis patients
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Does relationship exist between severity of vitamin D deficiency and development of active TB?
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012
Evaluation of vitamin A, E and C supplement therapy on immunologic profiles of pulmonary tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 455s
Year: 2005
Effect of vitamin D levels on natural killer cells in diabetes mellitus patients with tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
The effectiveness of pulmonary TB treatment in patients with organic liver diseases, depending on the way of administration of anti-TB drugs
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015
Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015
The effectiveness of ²E² vitamin appliance in the complex treatment of adolescents suffering from pulmonary tuberculosis
Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents
Year: 2008
Tuberculosis in patients receiving treatment of TNF-alpha inhibitors
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Liver injury in treatment of latent tuberculosis infection - is the age cut-off for treatment justified?
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014
Vitamin D deficiency is very common in London tuberculosis contacts
Source: Eur Respir J 2004; 24: Suppl. 48, 34s
Year: 2004
Predictive factors of a delayed culture conversion under tuberculosis treatment
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept